康诺亚生物医药科技成都有限公司
CN
 
CN
Science & Technology
Research areasDrug CandidateTarget(Modality)Focused IndicationsLead
Identification
Pre-ClinicalINDClinical TrialsPartnerCommercial Rights
AutoimmunityCM310IL-4Rα(mAb)Moderate-to-severe AD--Adults

*BTD granted by CDE


Global
Moderate-to-severe AD--Children & Adolescents

Global
CRSwNP

Global
Moderate-to-severe eosinophilic asthma
Global ex mainland
China
SAR

Global
CM326TSLP(mAb)Moderate-to-severe AD

Global
CRSwNP

Global
Moderate-to-severe asthma
Global ex mainland
China
COPD
Global ex mainland
China
CM338MASP-2(mAb)IgA nephropathy

Global
OncologyCMG901

*FTD & ODD granted by FDA
*BTD granted by CDE

Claudin 18.2
(ADC)
Gastric and Other Solid tumors

未标题-2.jpg


hz1.png

123456789.jpeg
CM313CD38(mAb)RRMM, lymphoma and  other hematological malignancies

Global
SLE

Global
CM355CD20xCD3
(Bispecific)
Lymphoma
hz3.pngGlobal
CM336BCMAxCD3
(Bispecific)
RRMM

Global
CM350GPC3xCD3
(Bispecific)
Solid tumors

Global
CM369CCR8Tumors
hz3.pngGlobal